IPC signs 3 MoUs to strengthen pharmacovigilance, materiovigilance in Nagaland

The Indian Pharmacopoeia Commission (IPC), Ghaziabad, has signed three Memoranda of Understanding (MoU) with the Nagaland Medical Council, the Nagaland State Drugs Control Administration (NSDCA), Department of Health & Family Welfare, Nagaland, and the State Pharmacy Council, Government of Nagaland, the Ministry of Health said on Friday.

The MoUs were signed during the one-day training programme on pharmacovigilance and materiovigilance organised by IPC in collaboration with NSDCA.

“The collaboration seeks to strengthen pharmacovigilance and materiovigilance, promote adverse event reporting, build stakeholder capacity, expand adverse drug reaction (ADR) monitoring centres/ Medical Device Adverse Event Monitoring Centres (MDMCs), and advance safe medicine use through the National Formulary of India across healthcare facilities in Nagaland,” the Ministry said. Notably, the MoU with Nagaland Drugs Control Administration is IPC’s second MoU, followed by UPFDA, and the first of its kind in the North Eastern region.

The MoU with the Nagaland Medical Council is the first MoU with any State Medical Council in the country for the promotion of the Pharmacovigilance Programme of India and Materiovigilance Programme of India, aimed to promote patient safety up to the level of primary health centres in the country.